San Antonio Breast Cancer Symposium

POSITIVE Study Findings Shift Conversations on Pregnancy in ER+ Breast Cancer

January 06, 2023

Jamie Carroll, APRN, CNP, MSN, weighs in on how findings from the POSITIVE study may change dialogue surrounding pregnancy for women with estrogen receptor–positive breast cancer who wish to pause adjuvant therapy.

Black Women With HR+ Breast Cancer Experience Inferior Outcomes, Despite Comparable Recurrence Scores

January 01, 2023

Non-Hispanic Black patients with hormone receptor (HR)–positive/HER2-negative breast cancer were more likely to have worse outcomes vs non-Hispanic White, Asian, and Hispanic patients, even with similar 21-gene recurrence scores.